Report Detail
Global and United States Inhaled Nitric Oxide Delivery Device Market Report & Forecast 2022-2028
- RnM4420515 |
- 06 April, 2022 |
- Global |
- 105 Pages |
- QYResearch |
- Medical Devices & Consumables
Summary:
Market Analysis and Insights: Global and United States Inhaled Nitric Oxide Delivery Device Market
This report focuses on global and United States Inhaled Nitric Oxide Delivery Device market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Inhaled Nitric Oxide Delivery Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Inhaled Nitric Oxide Delivery Device for Children accounting for % of the Inhaled Nitric Oxide Delivery Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hypoxic Respiratory Failure (HRF) was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Inhaled Nitric Oxide Delivery Device market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Inhaled Nitric Oxide Delivery Device Scope and Market Size
Inhaled Nitric Oxide Delivery Device market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Inhaled Nitric Oxide Delivery Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Inhaled Nitric Oxide Delivery Device market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Inhaled Nitric Oxide Delivery Device market is segmented into
Inhaled Nitric Oxide Delivery Device for Children
Inhaled Nitric Oxide Delivery Device for Adults
Segment by Application, the Inhaled Nitric Oxide Delivery Device market is segmented into
Hypoxic Respiratory Failure (HRF)
Acute Hypoxemic Respiratory Failure (AHRF)
Chronic Obstructive Pulmonary Disease (COPD)
Others
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Inhaled Nitric Oxide Delivery Device Market Share Analysis
Inhaled Nitric Oxide Delivery Device market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Inhaled Nitric Oxide Delivery Device business, the date to enter into the Inhaled Nitric Oxide Delivery Device market, Inhaled Nitric Oxide Delivery Device product introduction, recent developments, etc.
The major vendors covered:
Mallinckrodt Pharmaceuticals
Getinge
Vero Biotech
LINDE
Beyond Air
Air Liquide Healthcare
Circassia Pharmaceuticals
NU MED
Bellerophon Therapeutics
Praxair Technology Inc.
Table of Contents
1 Study Coverage
- 1.1 Inhaled Nitric Oxide Delivery Device Product Introduction
- 1.2 Global Inhaled Nitric Oxide Delivery Device Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Inhaled Nitric Oxide Delivery Device Sales in US$ Million for the Year 2017-2028
- 1.2.2 Global Inhaled Nitric Oxide Delivery Device Sales in Volume for the Year 2017-2028
- 1.3 United States Inhaled Nitric Oxide Delivery Device Outlook 2017 VS 2022 VS 2028
- 1.3.1 United States Inhaled Nitric Oxide Delivery Device Sales in US$ Million for the Year 2017-2028
- 1.3.2 United States Inhaled Nitric Oxide Delivery Device Sales in Volume for the Year 2017-2028
- 1.4 Inhaled Nitric Oxide Delivery Device Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4.1 The Market Share of United States Inhaled Nitric Oxide Delivery Device in Global, 2017 VS 2022 VS 2028
- 1.4.2 The Growth Rate of Inhaled Nitric Oxide Delivery Device Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.5 Inhaled Nitric Oxide Delivery Device Market Dynamics
- 1.5.1 Inhaled Nitric Oxide Delivery Device Industry Trends
- 1.5.2 Inhaled Nitric Oxide Delivery Device Market Drivers
- 1.5.3 Inhaled Nitric Oxide Delivery Device Market Challenges
- 1.5.4 Inhaled Nitric Oxide Delivery Device Market Restraints
- 1.6 Study Objectives
- 1.7 Years Considered
2 Market by Type
- 2.1 Inhaled Nitric Oxide Delivery Device Market Segment by Type
- 2.1.1 Inhaled Nitric Oxide Delivery Device for Children
- 2.1.2 Inhaled Nitric Oxide Delivery Device for Adults
- 2.2 Global Inhaled Nitric Oxide Delivery Device Market Size by Type
- 2.2.1 Global Inhaled Nitric Oxide Delivery Device Sales in Value, by Type (2017, 2022 & 2028)
- 2.2.2 Global Inhaled Nitric Oxide Delivery Device Sales in Volume, by Type (2017, 2022 & 2028)
- 2.2.3 Global Inhaled Nitric Oxide Delivery Device Average Selling Price (ASP) by Type (2017, 2022 & 2028)
- 2.3 United States Inhaled Nitric Oxide Delivery Device Market Size by Type
- 2.3.1 United States Inhaled Nitric Oxide Delivery Device Sales in Value, by Type (2017, 2022 & 2028)
- 2.3.2 United States Inhaled Nitric Oxide Delivery Device Sales in Volume, by Type (2017, 2022 & 2028)
- 2.3.3 United States Inhaled Nitric Oxide Delivery Device Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
- 3.1 Inhaled Nitric Oxide Delivery Device Market Segment by Application
- 3.1.1 Hypoxic Respiratory Failure (HRF)
- 3.1.2 Acute Hypoxemic Respiratory Failure (AHRF)
- 3.1.3 Chronic Obstructive Pulmonary Disease (COPD)
- 3.1.4 Others
- 3.2 Global Inhaled Nitric Oxide Delivery Device Market Size by Application
- 3.2.1 Global Inhaled Nitric Oxide Delivery Device Sales in Value, by Application (2017, 2022 & 2028)
- 3.2.2 Global Inhaled Nitric Oxide Delivery Device Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 Global Inhaled Nitric Oxide Delivery Device Average Selling Price (ASP) by Application (2017, 2022 & 2028)
- 3.3 United States Inhaled Nitric Oxide Delivery Device Market Size by Application
- 3.3.1 United States Inhaled Nitric Oxide Delivery Device Sales in Value, by Application (2017, 2022 & 2028)
- 3.3.2 United States Inhaled Nitric Oxide Delivery Device Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 United States Inhaled Nitric Oxide Delivery Device Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Inhaled Nitric Oxide Delivery Device Competitor Landscape by Company
- 4.1 Global Inhaled Nitric Oxide Delivery Device Market Size by Company
- 4.1.1 Top Global Inhaled Nitric Oxide Delivery Device Manufacturers Ranked by Revenue (2021)
- 4.1.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturer (2017-2022)
- 4.1.3 Global Inhaled Nitric Oxide Delivery Device Sales by Manufacturer (2017-2022)
- 4.1.4 Global Inhaled Nitric Oxide Delivery Device Price by Manufacturer (2017-2022)
- 4.2 Global Inhaled Nitric Oxide Delivery Device Concentration Ratio (CR)
- 4.2.1 Inhaled Nitric Oxide Delivery Device Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Inhaled Nitric Oxide Delivery Device in 2021
- 4.2.3 Global Inhaled Nitric Oxide Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Inhaled Nitric Oxide Delivery Device Manufacturing Base Distribution, Product Type
- 4.3.1 Global Inhaled Nitric Oxide Delivery Device Manufacturers, Headquarters and Distribution of Producing Region
- 4.3.2 Manufacturers Inhaled Nitric Oxide Delivery Device Product Type
- 4.3.3 Date of International Manufacturers Enter into Inhaled Nitric Oxide Delivery Device Market
- 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4.5 United States Inhaled Nitric Oxide Delivery Device Market Size by Company
- 4.5.1 Top Inhaled Nitric Oxide Delivery Device Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Inhaled Nitric Oxide Delivery Device Revenue by Players (2020, 2021 & 2022)
- 4.5.3 United States Inhaled Nitric Oxide Delivery Device Sales by Players (2020, 2021 & 2022)
5 Global Inhaled Nitric Oxide Delivery Device Market Size by Region
- 5.1 Global Inhaled Nitric Oxide Delivery Device Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Inhaled Nitric Oxide Delivery Device Market Size in Volume by Region (2017-2028)
- 5.2.1 Global Inhaled Nitric Oxide Delivery Device Sales in Volume by Region: 2017-2022
- 5.2.2 Global Inhaled Nitric Oxide Delivery Device Sales in Volume Forecast by Region (2023-2028)
- 5.3 Global Inhaled Nitric Oxide Delivery Device Market Size in Value by Region (2017-2028)
- 5.3.1 Global Inhaled Nitric Oxide Delivery Device Sales in Value by Region: 2017-2022
- 5.3.2 Global Inhaled Nitric Oxide Delivery Device Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Inhaled Nitric Oxide Delivery Device Market Size YoY Growth 2017-2028
- 6.1.2 North America Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Inhaled Nitric Oxide Delivery Device Market Size YoY Growth 2017-2028
- 6.3.2 Europe Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Inhaled Nitric Oxide Delivery Device Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Mallinckrodt Pharmaceuticals
- 7.1.1 Mallinckrodt Pharmaceuticals Corporation Information
- 7.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
- 7.1.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
- 7.1.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Products Offered
- 7.1.5 Mallinckrodt Pharmaceuticals Recent Development
- 7.2 Getinge
- 7.2.1 Getinge Corporation Information
- 7.2.2 Getinge Description and Business Overview
- 7.2.3 Getinge Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
- 7.2.4 Getinge Inhaled Nitric Oxide Delivery Device Products Offered
- 7.2.5 Getinge Recent Development
- 7.3 Vero Biotech
- 7.3.1 Vero Biotech Corporation Information
- 7.3.2 Vero Biotech Description and Business Overview
- 7.3.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
- 7.3.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Products Offered
- 7.3.5 Vero Biotech Recent Development
- 7.4 LINDE
- 7.4.1 LINDE Corporation Information
- 7.4.2 LINDE Description and Business Overview
- 7.4.3 LINDE Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
- 7.4.4 LINDE Inhaled Nitric Oxide Delivery Device Products Offered
- 7.4.5 LINDE Recent Development
- 7.5 Beyond Air
- 7.5.1 Beyond Air Corporation Information
- 7.5.2 Beyond Air Description and Business Overview
- 7.5.3 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
- 7.5.4 Beyond Air Inhaled Nitric Oxide Delivery Device Products Offered
- 7.5.5 Beyond Air Recent Development
- 7.6 Air Liquide Healthcare
- 7.6.1 Air Liquide Healthcare Corporation Information
- 7.6.2 Air Liquide Healthcare Description and Business Overview
- 7.6.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
- 7.6.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Products Offered
- 7.6.5 Air Liquide Healthcare Recent Development
- 7.7 Circassia Pharmaceuticals
- 7.7.1 Circassia Pharmaceuticals Corporation Information
- 7.7.2 Circassia Pharmaceuticals Description and Business Overview
- 7.7.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
- 7.7.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Products Offered
- 7.7.5 Circassia Pharmaceuticals Recent Development
- 7.8 NU MED
- 7.8.1 NU MED Corporation Information
- 7.8.2 NU MED Description and Business Overview
- 7.8.3 NU MED Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
- 7.8.4 NU MED Inhaled Nitric Oxide Delivery Device Products Offered
- 7.8.5 NU MED Recent Development
- 7.9 Bellerophon Therapeutics
- 7.9.1 Bellerophon Therapeutics Corporation Information
- 7.9.2 Bellerophon Therapeutics Description and Business Overview
- 7.9.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
- 7.9.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Products Offered
- 7.9.5 Bellerophon Therapeutics Recent Development
- 7.10 Praxair Technology Inc.
- 7.10.1 Praxair Technology Inc. Corporation Information
- 7.10.2 Praxair Technology Inc. Description and Business Overview
- 7.10.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
- 7.10.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Products Offered
- 7.10.5 Praxair Technology Inc. Recent Development
8 Industry Chain and Sales Channels Analysis
- 8.1 Inhaled Nitric Oxide Delivery Device Industry Chain Analysis
- 8.2 Inhaled Nitric Oxide Delivery Device Key Raw Materials
- 8.2.1 Key Raw Materials
- 8.2.2 Inhaled Nitric Oxide Delivery Device Distributors
- 8.3 Inhaled Nitric Oxide Delivery Device Production Mode & Process
- 8.4 Inhaled Nitric Oxide Delivery Device Sales and Marketing
- 8.4.1 Inhaled Nitric Oxide Delivery Device Sales Channels
- 8.4.2 Inhaled Nitric Oxide Delivery Device Distributors
- 8.5 Inhaled Nitric Oxide Delivery Device Customers
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.2 Data Source
- 10.2 Author Details
Summary:
Get latest Market Research Reports on Inhaled Nitric Oxide Delivery Device. Industry analysis & Market Report on Inhaled Nitric Oxide Delivery Device is a syndicated market report, published as Global and United States Inhaled Nitric Oxide Delivery Device Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Inhaled Nitric Oxide Delivery Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
